The closing price of Vincerx Pharma Inc (NASDAQ: VINC) was $7.03 for the day, up 27.12% from the previous closing price of $5.53. In other words, the price has increased by $+1.50 from its previous closing price. On the day, 2037188 shares were traded.
Ratios:
Our analysis of VINC’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.58 and its Current Ratio is at 2.58. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on January 14, 2022, initiated with a Buy rating and assigned the stock a target price of $25.
On December 23, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $25.
On November 01, 2021, SVB Leerink started tracking the stock assigning a Outperform rating and target price of $24.SVB Leerink initiated its Outperform rating on November 01, 2021, with a $24 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 11 ’23 when Seelenberger Alexander A. bought 10,500 shares for $0.95 per share. The transaction valued at 9,968 led to the insider holds 30,280 shares of the business.
Hamdy Ahmed MD bought 5,400 shares of VINC for $5,167 on Aug 10 ’23. The insider now owns 96,060 shares after completing the transaction at $0.96 per share. On Aug 10 ’23, another insider, THOMAS TOM C, who serves as the insider of the company, bought 5,000 shares for $0.95 each. As a result, the insider paid 4,750 and bolstered with 219,935 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VINC now has a Market Capitalization of 117.81M and an Enterprise Value of 99.77M.
Stock Price History:
Over the past 52 weeks, VINC has reached a high of $5.66, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is 1.88, while the 200-Day Moving Average is calculated to be 1.25.
Shares Statistics:
VINC traded an average of 918.15K shares per day over the past three months and 971.82k shares per day over the past ten days. A total of 21.24M shares are outstanding, with a floating share count of 13.41M. Insiders hold about 37.29% of the company’s shares, while institutions hold 45.87% stake in the company. Shares short for VINC as of Feb 15, 2024 were 241.38k with a Short Ratio of 0.26, compared to 512.52k on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.13% and a Short% of Float of 1.55%.
Earnings Estimates
The firm’s stock currently is rated by 3 analysts. On average, analysts expect EPS of -$0.37 for the current quarter, with a high estimate of -$0.24 and a low estimate of -$0.44, while EPS last year was -$0.65. The consensus estimate for the next quarter is -$0.19, with high estimates of -$0.19 and low estimates of -$0.19.
Analysts are recommending an EPS of between -$1.9 and -$2.14 for the fiscal current year, implying an average EPS of -$2.04. EPS for the following year is -$0.58, with 2 analysts recommending between -$0.5 and -$0.66.
